Benjamin Graham · Defensive deep-value investing
Is ACADIA Pharmaceuticals Inc. (ACAD) a Benjamin Graham Stock?
Meets 5/7 Graham criteria, partially qualifies.
49/100
Does not fit
5/7 criteria passed
Benjamin Graham's Criteria, Applied to ACAD
P/E ≤ 15
key9.6x
P/B ≤ 1.5
key2.9x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.0x
How ACAD Scores on Other Strategies
Live Financial Snapshot
Market cap
$3.55B
P/E (TTM)
9.6x
ROIC (TTM)
6.17%
Gross margin
91.47%
Other Benjamin Graham fit reports
Frequently Asked Questions
What is ACAD's Benjamin Graham fit score?
ACAD scores 49/100 on our Benjamin Graham fit engine. Meets 5/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own ACAD?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends ACAD.
How often is this score updated?
ACAD's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Benjamin Graham personally owns or recommends ACAD.
